ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 404 filers reported holding ENCOMPASS HEALTH CORP in Q1 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $343,891 | +3.4% | 5,120 | +4.2% | 0.00% | 0.0% |
| Q2 2023 | $332,717 | +32.4% | 4,914 | +5.8% | 0.00% | 0.0% |
| Q1 2023 | $251,358 | -9.5% | 4,646 | +0.1% | 0.00% | 0.0% |
| Q4 2022 | $277,667 | +10.6% | 4,642 | +3.5% | 0.00% | -50.0% |
| Q2 2022 | $251,000 | -32.9% | 4,487 | -14.4% | 0.00% | 0.0% |
| Q1 2022 | $374,000 | +3.0% | 5,244 | -5.5% | 0.00% | 0.0% |
| Q4 2021 | $363,000 | -21.9% | 5,547 | -10.1% | 0.00% | -50.0% |
| Q3 2021 | $465,000 | -12.1% | 6,167 | -8.7% | 0.00% | -20.0% |
| Q2 2021 | $529,000 | +5.6% | 6,757 | +10.9% | 0.01% | 0.0% |
| Q1 2021 | $501,000 | +27.8% | 6,094 | +29.1% | 0.01% | 0.0% |
| Q4 2020 | $392,000 | +14.6% | 4,721 | -9.2% | 0.01% | -16.7% |
| Q3 2020 | $342,000 | -90.8% | 5,198 | -91.2% | 0.01% | -90.2% |
| Q2 2020 | $3,705,000 | +21.0% | 58,804 | +17.1% | 0.06% | -9.0% |
| Q1 2020 | $3,061,000 | +37.4% | 50,203 | +56.5% | 0.07% | +91.4% |
| Q4 2019 | $2,227,000 | – | 32,073 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |